Key points are not available for this paper at this time.
Introduction 0.05 for all). Exercise improved diastolic (E/e’: Sedentary: -34.69 ± 1.25 vs Exercise: -29.48 ± 1.92, p=0.04, n=10), systolic function (FS: Sedentary: 54.24% ± 2.94 vs Exercise: 62.33% ± 2.12, p=0.04, n=10) and cardiac METTL3 protein expression. These effects of exercise were canceled by CM-specific METTL3 knockout (FS: Control: 57.17% ± 1.85 vs Knockout: 28.49% ± 3.98, p0.001, n=8). In HFD+STZ mice, CM-specific METTL3 overexpression improves diastolic and systolic (FS: Control: 44.31% ± 2.2 vs Overexpression: 50.56% ± 1.64, p=0.03, n=8) functions. METTL3 functioned by increasing m6A deposition in YBX-1 and promoted its transcription. CM-specific YBX-1 overexpression improved diastolic and systolic functions as well as reduced cardiac oxidative stress. Conclusion: METTL3 regulates DiaCM through YBX-1 and is essential for cardiac benefits of exercise in DiaCM. METTL3 is a promising therapeutic target for combating DiaCM. Disclosure C. Wang: None. J. Kang: None. A. Sugai-Munson: None. Z. Liu: None. W. Yao: None. H. Li: None. Funding National Institutes of Health (R21AG077040); American Heart Association (20CDA35310184)
Wang et al. (Fri,) studied this question.